McAnear Justin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Sep 3, 2021
- Accession no.
- 0001209191-21-054900
- Filed
- Sep 3, 2021
- Trade date
- Sep 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McAnear Justin J.CIK 0001786386 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +10,000 | $5.04 | +$50,400 | 49,100 | Direct | |
| Sep 1, 2021 | Class A Common Stock | SSaleDisposed | −374 | $174.87F2 | −$65,401.38 | 48,726 | Direct | |
| Sep 1, 2021 | Class A Common Stock | SSaleDisposed | −1,139 | $175.95F3 | −$200,407.05 | 47,587 | Direct | |
| Sep 1, 2021 | Class A Common Stock | SSaleDisposed | −2,200 | $177.00F4 | −$389,400 | 45,387 | Direct | |
| Sep 1, 2021 | Class A Common Stock | SSaleDisposed | −4,747 | $177.87F5 | −$844,348.89 | 40,640 | Direct | |
| Sep 1, 2021 | Class A Common Stock | SSaleDisposed | −1,540 | $178.80F6 | −$275,352 | 39,100 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 390,159 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $174.20 to $175.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $175.34 to $176.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $176.39 to $177.355. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $177.41 to $178.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $178.41 to $179.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.